|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ORIGINAL RESEARCH COMMUNICATION |
1 From the University of North Carolina at Chapel Hill, Chapel Hill, NC (LSA); the Hubert Department of Global Health, Emory University, Atlanta, GA (RM and ADS); Universidade Federal de Pelotas, Pelotas, Brazil (PCH and CGV); the Sitaram Bhartia Institute of Science and Research, New Delhi, India (HSS); the Centre for Chronic Disease Control, New Delhi, India (DP); the MRC Epidemiology Resource Centre, University of Southampton, Southampton, United Kingdom (AKW); the Department of Paediatrics, MRC Mineral Metabolism Research Unit, University of the Witwatersrand, Johannesburg, South Africa (SAN); the University of Leeds, Leeds, United Kingdom (DLD); and the Office of Population Studies Foundation, Cebu, Philippines (NRL).
2 Supported by a grant from the Wellcome Trust of the United Kingdom. Funding for each of the individual cohort studies was as follows: Guatemala INTC (US National Institutes of Health and the US National Science Foundation), Pelotas (recent phases of the cohort study supported by the Wellcome Trust's Health Consequences of Population Change Programme), New Delhi (original cohort study supported by the US National Center for Health Statistics and the Indian Council of Medical Research; more recent phases supported by the British Heart Foundation, the Medical Research Council UK, and the Indian Council of Medical Research), Birth-to-Twenty (the Wellcome Trust, Human Sciences Research Council, South African Medical Research Council, the Mellon Foundation, the South-African Netherlands Programme on Alternative Development, and the Anglo American Chairman's Fund), and Cebu, Philippines (most recent follow-up surveys supported by the US National Institutes of Health, Fogarty International Center R01 TW05596).
3 Reprints not available. Address correspondence to LS Adair, Carolina Population Center, University of North Carolina at Chapel Hill, CB# 8120, University Square, 123 West Franklin Street, Chapel Hill, NC 27516-2524. E-mail: linda_adair{at}unc.edu.
for the COHORTS group
| ABSTRACT |
|---|
|
|
|---|
Objective: We aimed to determine how birth weight (BW) and weight gain to midchildhood relate to blood pressure (BP) in young adults.
Design: We pooled data from birth cohorts in Brazil, Guatemala, India, the Philippines, and South Africa. We used conditional weight (CW), a residual of current weight regressed on prior weights, to represent deviations from expected weight gain from 0 to 12, 12 to 24, 24 to 48 mo, and 48 mo to adulthood. Adult BP and risk of prehypertension or hypertension (P/HTN) were modeled before and after adjustment for adult body mass index (BMI) and height. Interactions of CWs with small size-for-gestational age (SGA) at birth were tested.
Results: Higher CWs were associated with increased BP and odds of P/HTN, with coefficients proportional to the contribution of each CW to adult BMI. Adjusted for adult height and BMI, no child CW was associated with adult BP, but 1 SD of BW was related to a 0.5-mm Hg lower systolic BP and a 9% lower odds of P/HTN. BW and CW associations with systolic BP and P/HTN were not different between adults born SGA and those with normal BW, but higher CW at 48 mo was associated with higher diastolic BP in those born SGA.
Conclusions: Greater weight gain at any age relates to elevated adult BP, but faster weight gains in infancy and young childhood do not pose a higher risk than do gains at other ages.
| INTRODUCTION |
|---|
|
|
|---|
The long-term consequences of rapid weight gain in infancy and early childhood in populations with a high prevalence of early childhood undernutrition are unknown. It is critical to determine whether any long-term deleterious effects depend on the timing of rapid weight gain. Evidence from India (14), Guatemala (15), and Brazil (16) suggests that timing of weight gain affects adult body composition, which, in turn, is related to chronic disease risk. These studies show that faster infant and early childhood weight gain relates more strongly to adult lean mass than to adiposity, whereas weight gain in later childhood and adolescence contributes more to adult adiposity.
We used data from 5 low- and middle-income countries to examine how birth weight (BW) and weight gain into midchildhood relate to blood pressure (BP) in young adults. We study BP because it tracks into adulthood (17, 18) and is a significant risk factor for cardiovascular disease. Our objective was to address the following questions: 1) to what degree are BW and greater than expected weight gain in early to midchildhood associated with adult BP; 2) among adults who are the same height and weight, does it matter when a period of higher than expected weight gain occurred; and 3) does the association of early childhood weight gain with later BP differ between those who were born small and those adequate for gestational age (AGA).
| SUBJECTS AND METHODS |
|---|
|
|
|---|
|
Outcome variables
BP, the main outcome of interest, was measured with an aneroid sphygmomanometer in Pelotas, with a mercury sphygmomanometer in Cebu, and with digital devices in Guatemala (model UA-767; A&D Medical, San Jose, CA), for the Bt20 (Omron M6; Omron, Kyoto, Japan) and in New Delhi (Omron 711). Appropriate cuff sizes were used, and the participants were measured while seated after a 5–10 min rest. For Pelotas, New Delhi and Bt20, we used the mean of 2 measurements (for Bt20, 3 measurements were taken but the first was discarded). For Cebu and Guatemala, 3 measurements were averaged. BP was represented as a continuous variable [focus on systolic BP (SBP), but diastolic BP (DBP) also reported] or categorized to represent prehypertension and hypertension (P/HTN), defined as SBP
130 mm Hg or DBP
80 mm Hg for adults. Because Bt20 participants were adolescents, we defined P/HTN for them as SBP or DBP greater than or equal to the 90th percentile of age-, sex-, and height-specific cutoffs as recommended by the National High Blood Pressure Education Program Working Group (25). Antihypertensive medications were used by <0.5% of the participants. We included prehypertension in our outcome because of the young age of the study participants.
Infant and child anthropometric measures
BW was measured by research teams in Pelotas, New Delhi, and Guatemala. In Cebu, BW was measured by birth attendants who had been provided with mechanical scales for home births (60%) or was obtained from hospital records for the remainder. In Bt20, weight was obtained from reliable birth records (26). Subsequent weights were measured by research teams using standard techniques (14, 19, 20, 22, 24) and then converted to weight-for-age z (WAZ) scores using the WHO Growth Standards (27). The New Delhi weight data contributed to the pooled data set as values interpolated to exact ages of 12, 24, and 48 mo by using individual weight curves. Midchildhood weight was measured at a mean age of 48 mo in Pelotas, New Delhi, and Guatemala; at 60 mo for Bt20; and at 102 mo in Cebu. To make midchildhood weight comparable across sites, we imputed 48-mo z scores for Bt20 and Cebu participants, assuming a linear change in z score from 24 to 60 or 102 mo respectively, and back-transformed the resulting z scores into weight (in kg).
Gestational age
Gestational age for most participants was based on a mother's report of the date of her last menstrual period and infant birth date. For Cebu participants with low BW, or whose mothers had pregnancy complications, Ballard scores obtained by clinical assessment were used instead. Small for gestational age (SGA) was defined as a BW below the age- and sex-specific 10th percentile of the BW distribution published by Williams et al (28).
Anthropometric measures at follow-up
Body mass index (BMI; in kg/m2) was calculated from measured weight and height at age 15 y in Bt20 and in young adulthood for the other sites.
Other covariates
Socioeconomic status at birth and in young adulthood was represented by maternal education (or paternal occupation in New Delhi) and/or by ownership of various household assets. An assets score was created for each site (29), and study participants were characterized by quintiles of these scores. Site-specific variables considered as potential confounders included race-ethnicity for Pelotas and Bt20, urban-rural residence for Cebu, and village of residence for Guatemala (to represent village size and nutrition intervention study design).
Conditional weight
To eliminate some statistical problems associated with modeling highly correlated weight measures, we used conditional weight (CW) variables to represent the component of weight at a given age that is uncorrelated with earlier weight measures (30, 31). CWs were calculated as the residuals from site- and sex-stratified linear regressions of weight (kg) at a given age on BW and any prior weights. The regression models also included exact age at measurement, and squared prior weight terms to account for nonlinearities. CW is thus the deviation in an individual's weight from its expected value, given his or her prior weights. CWs are estimated by using an individual's own prior weight data, but age- and sex-specific population data are used to generate the estimation equation. When a CW variable is included in a multiple regression with the variables it is conditioned on (BW and any prior weights), it can be interpreted as change in weight over the prior interval.
The CW residuals were standardized to allow comparisons across ages. For comparability in analyses that include CW, we also expressed BW as an internal sex- and site-specific z score. At 12, 24, and 48 mo, 1 SD of CW at the median corresponded to about 1.0, 0.7, and 0.9 kg, respectively, and 1 SD of BW corresponded to 0.5 kg.
Body composition
We calculated percentage body fat at follow-up using site-specific methods: bioimpedance and estimated percentage body fat with a deuterium-validated equation in Pelotas (32); weight, height, and abdominal or waist circumferences with an equation validated by hydrostatic weighing in Guatemala (33); dual-energy X-ray absorptiometry (Hologic Delphi) for the Bt20; and skinfold-thickness equations based on published conversion tables (34) validated for Asian populations (35) in Cebu and New Delhi. Fat mass (kg) was calculated as percentage body fat x weight, and lean mass (kg) was calculated as adult weight minus fat mass.
Analysis
We first assessed unadjusted differences in mean weight at birth and during childhood in groups with and without P/HTN. Differences by P/HTN status, stratified by sex and site, were evaluated by t test. We then estimated linear (for continuous SBP and DBP) or logistic (for P/HTN) regression models. All models included age at follow-up, sex, and site. We found no strong evidence of heterogeneity by sex or site. Gestational age, socioeconomic status, and site-specific potential confounders were omitted because they were not associated with adult BP and did not change the coefficients for the variables of primary interest. We developed a series of models. The first included the BW z score calculated from the WHO reference and is presented for comparison with other studies. The second included a site- and sex-specific internal BW z score and CW at 12, 24, and 48 mo, similar to the approach used by others (30, 31). We compared models with 1) no adjustment for adult size, 2) adjustment for adult BMI, and 3) adjustment for adult BMI and height. Adjustment for adult measures addressed whether higher than expected weight gain at specific ages in childhood related to BP or odds of P/HTN among adults with the same BMI (or BMI and height). We adjusted for adult height because it is a strong predictor of BP in healthy individuals, particularly in adolescents (36), and it is highly related to lean body mass.
The third set of models included adult CW but not BMI, because adult CW and BMI are very highly correlated. These models addressed a different question, namely, whether higher than expected weight at any age (including adulthood) related to adult BP and odds of P/HTN. To aid in the interpretation of these models (given the strong association of BMI with BP), we also estimated a linear regression model to determine how each CW predicted adult BMI.
We assessed whether CW related differently to BP or odds of P/HTN in adults who were born SGA compared with those born AGA by adding to model 2 a binary variable (=1 if born SGA) and terms for the interaction of SGA with BW and of SGA with CW at each age. We tested whether the association of childhood CW with adult BP differed across the full range of BW by including an interaction of BW with each CW.
In a separate analysis, we aimed to isolate possible pathophysiologic effects of excess fatness on BP from physiologic variation in BP related to height and lean body mass. We first estimated site- and sex-specific residuals of SBP and DBP predicted from age, height, and lean mass (representing a deviation from what would be expected based on these variables) and then used these residuals as outcomes. This analysis could not be conducted for Pelotas females because body-composition data were not available for them.
To assess potential selection bias related to the exclusion of the large number of Pelotas and Bt20 participants with missing 12-mo weight measures, we created a 24-mo CW variable conditional only on BW. We tested whether BW and CW at 24 and 48 mo had similar associations with adult SBP and risk of P/HTN in our main analysis sample (n = 4335) and those excluded only because of missing 12-mo data (n = 3842). Results were considered to differ if the P value for the interaction of being in the analytic sample with BW or CW was <0.10.
| RESULTS |
|---|
|
|
|---|
|
|
|
|
|
0.5 kg) increase in BW was associated with a 0.5–0.6-mm Hg decrease in SBP and a 9% reduction in odds of P/HTN. In a DBP model adjusted for adult BMI and height (comparable with that of model 2C in Table 3), BW was inversely associated with DBP (–0.51 mm Hg/SD; 95% CI: –0.82, –0.21), but CW measures were unrelated to DBP. In models that included adult CW with or without adjustment for adult height (model 3C compared with model 3A in Tables 3 and 4), BW was unrelated to SBP or P/HTN, but all CW variables were strongly and positively associated with SBP and P/HTN. Adjustment for adult height (model 3C) increased the coefficients for the childhood CW terms. Taller adult stature was related to a lower odds of P/HTN in model 3C. The pattern of results for DBP was similar.
BW was more highly correlated with adult height (r = 0.25) than with adult BMI (r = 0.12), with correlations based on site- and sex-specific z scores. CW at all ages strongly predicted adult BMI. The sizes of the coefficients relating BW and CW to adult SBP in model 3C were roughly proportional to the coefficients relating BW and CW to adult BMI (Figure 3).
|
To determine whether the association of BW and CW with BP or risk of P/HTN differed according to whether an adult was born SGA, we specified model 2C to include a main effect of SGA and interactions of SGA with each CW (Table 5). BW was not included in these models because it is highly related to SGA. Being born SGA was associated with higher SBP and an increased odds of P/HTN, but there were no significant interactions of SGA with CW at any age. For DBP, there was no main effect of SGA, but higher CW was associated with higher DBP at 48 mo in those who were born SGA. In the alternate analysis designed to test whether CW had the same effect across the full BW distribution, no BW by CW interaction term was significant for SBP or DBP.
|
|
| DISCUSSION |
|---|
|
|
|---|
In our sample, the associations of BW and CW at 12, 24, and 48 mo with adult BP roughly reflected the relative contribution of weight gain in these time periods to adult BMI. For example, children gained about twice as much weight in the first than in the second year of life. CW at 12 mo had a coefficient
2 times that of CW at 24 mo (Table 3). Adult CW (higher than expected gain from 48 mo to adulthood) had the largest BP coefficient.
When adult size (indexed by BMI and height) was held constant, there was no interval through midchildhood when greater than expected weight gain contributed to elevated BP. However, because models adjusted for adult height and BMI exclude adult CW (because of the high correlation of these variables), we concluded that weight gain after midchildhood is an important contributor to risk of elevated BP. This is consistent with other studies, which showed the importance of heterogeneous growth trajectories, including a pattern of relative thinness to age 2 y followed by more rapid growth to age 11 y (12) or excess weight gain after age 7 y (37). Further exploration of other weight and height trajectories is planned by the COHORTS group.
Consistent with a large body of research (38, 39) and with our prior metaregression analysis (29), we found significant inverse associations of BW with adult SBP and DBP and odds of P/HTN after adjustment for adult BMI and height. The size of these effects is consistent with previously published studies (equivalent to 1.1 mm Hg and a 19% reduction in odds of P/HTN per kg BW) (38, 40).
Concerns have been raised about the interpretation of BW associations in models that adjust for BMI measured concurrent with the BP outcome. Because of the positive association of BW with adult BMI and of BMI with BP, negative shifts in the BW coefficients after adjustment for BMI have been attributed to a bias resulting from "reversal paradox" (41), and the use of CW does not entirely free us of this concern (42). We opted to present unadjusted and adjusted results because, without adjustment for adult size, an independent effect of timing of weight gain cannot be estimated. Adjustment for adult BMI showed a significant inverse association of BW with adult SBP (models 2C and 3C), which was strengthened with further adjustment for adult height. This may reflect the higher correlation of BW with adult height and lean mass than with BMI or fat mass in our sample. We included adult height in our models because it is an important determinant of BP in healthy adolescents and was particularly relevant for the Bt20 cohort. Height is also an indicator of lean body mass; thus, adjustment for height may isolate the adverse effects of adult body fat on BP. It is interesting to note that in model 3C, which included CW through adulthood, taller stature was associated with lower odds of P/HTN. Ideally, we would like to have had complete length data for all of the cohorts, so that we could shed more light on the relative importance of weight gain and linear growth in childhood.
Given the particular importance in low- and middle-income countries of promoting early compensatory growth in SGA infants to reduce their risk of morbidity and mortality and to promote better cognitive outcomes, we tested whether higher CW related differently to BP in individuals who were SGA. Whereas SGA was related to higher SBP, the relation of CW to SBP was not different between adults who were born SGA and those born AGA, nor did this relation differ across the full range of BWs seen in our samples. Higher CW at 48 mo was associated with higher DBP and odds of P/HTN in adults who were born SGA. This could have been a chance finding or it may suggest that midchildhood growth is an important time for development of risk of elevated DBP in those with a history of prenatal growth restriction.
Several methodologic aspects of our study merit consideration. Integration of data from 5 cohorts for a pooled data analysis raises concerns about the comparability of measures across sites and whether the relations of interest vary substantially by site. Because of the variation in the timing of the midchildhood weight measurement, we imputed weight at 48 mo for the Bt20 and Cebu cohorts. CW coefficients through midchildhood were not substantially different when the actual 60-mo and 102-mo values were used for these sites, so we judged that the benefits of including these children in the analysis outweighed any potential biases related to imputation. Age at follow-up differed among the sites. Bt20 participants were adolescents, whereas the other cohorts included young adults. We addressed this by using a site-specific definition of P/HTN for Bt20 and adjusted for age in all models. We found no heterogeneity of effects by site or sex. Alternate models, which included additional potential confounders, including site-specific variables, produced no notable differences in the coefficients for BW or CW in childhood compared with our more parsimonious models. Despite substantial differences in infant and child weight, and adult age, height, BMI and BP, the similarity across sites of the relations of BW and CW to adult SBP enhances our confidence that we have identified biologically meaningful relations.
A final concern was with sample selection bias. Our analysis sample included a subset of participants with complete growth data in childhood (required to estimate the full set of CW variables) as well adult anthropometric and BP measurements. It differs from the full sample of cohort participants owing to attrition typical of longitudinal studies and to study design (eg, the loss of relatively more participants from the Pelotas and Bt20 cohorts). Results may be biased if BW and CW relate differently to adult BP in the included compared with excluded participants. Whereas it was not possible to estimate the effects of attrition, we used CW variables estimated without 12-mo data to compare selected models in our analysis sample to models run with the sample excluded owing to missing 12-mo data. BW coefficients were significantly smaller in our analysis sample, but CWs at 24 and 48 mo were unrelated to SBP or odds of P/HTN in both samples. The difference in the BW coefficient was accounted for primarily by the selectivity in the Pelotas sample. It is possible that seasonality played a role, because the Pelotas participants with data at 12 mo were those born between January and April.
Investigations of prenatal and early child growth effects on adult BP have been disproportionately carried out in high-income countries (39) and most have estimated the effects of weight gain without attention to the high level of correlation among weight measures at different ages (43–46). An exception to the latter is a recent study that used a linear spline random-effects model to show that higher weight gains in the first 5 mo and from 21 mo to 5 y were associated with higher BP (47).
Our study makes a unique contribution to the extant literature with its focus on samples from 5 low- and middle-income countries. In these settings, where chronic diseases of adulthood are rapidly emerging as major public health problems, the possible long-term risks of rapid child growth must be weighed against the well-established benefits of compensatory weight gain in growth-restricted children (4, 5). Evidence from our 5 birth cohorts suggests that higher weight gain in early life is only associated with elevated adult BP to the degree that early growth predicts adult BMI. However, at the same level of adult BMI, we found no association of weight gain from infancy to midchildhood to adult BP or risk of P/HTN. Furthermore, we confirmed prior studies showing that reduced fetal growth increases the risk of elevated BP in later life.
Because of its known association with height and BMI, BP may be more strongly affected by faster weight gain at any age than other chronic diseases and risk factors. This possibility will be tested by future analyses of the COHORTS data set addressing outcomes related to body composition, glucose concentrations, and lipid profiles. We will also look into how early growth might contribute to positive human capital outcomes, including school attainment and adult height. The evidence thus far suggests that the positive consequences of faster early weight gain in low- and middle-income countries outweigh its potential hazards (29). Nonetheless, prevention of overweight and obesity in children and young adults needs to be a priority to reduce the rising burden of cardiovascular disease in developing and transitional countries.
| ACKNOWLEDGMENTS |
|---|
The authors' responsibilities were as follows—The COHORTS group was responsible for the development of the concept and methods; LSA: conducted the data analysis and prepared the first draft of the manuscript; each of the 5 studies was represented by one or more authors who participated in the design and/or implementation of the original study or follow-up surveys (Guatemala: RM and ADS; Pelotas: PCH and CGV; New Delhi: HSS and DP; Bt20: SAN; Cebu: LSA). All authors interpreted the results and helped revise the manuscript. None of the authors had any conflicts of interest.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
K. Casazza and O. Thomas Do Dietary Modifications Made Prior to Pubertal Maturation Have the Potential to Decrease Obesity Later in Life? A Developmental Perspective ICAN: Infant, Child, & Adolescent Nutrition, October 1, 2009; 1(5): 271 - 281. [Abstract] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |